After 4 weeks of treatment, infusion of KCs through the tail vein was shown to ameliorate liver fibrosis induced by CCl4 in mice, indicating that KCs may be another source for macrophage therapy (Li and He, 2021). The gene discussed is TBCE; the disease is Hepatic fibrosis.